No abstract

Objective: In this study, we aimed to compare [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging to detect lesions in multiple myeloma. Methods: A total of 14 patients with multiple myeloma who underwent [68Ga]FAPI PET/CT and [18F]FDG PET/CT imaging were included in this retrospective study. SUVmax values of [68Ga]FAPI and [18F]FDG were compared according to lesion locations. Also, lesion localization ability of both imaging methods was compared on the patient basis. Results: In 4 of 14 patients, [68Ga]FAPI PET/CT and [18F]FDG PET/CT have not detected any bone lesions. In 8 of the remaining 10 patients [18F]FDG PET/CT detected bone lesions but in this group, 6 patients showed more higher SUVmax values than [18F]FDG PET/CT in [68Ga]FAPI PET/CT.In contrast, 2 of 8 patients showed more higher SUVmax values than [68Ga]FAPI PET/CT in [18F]FDG PET/CT. Moreover, [68Ga]FAPI PET/CT detected bone lesions in two patients, which werenot detected by [18F]FDG PET/CT. Also, in five patients, [68Ga]FAPI PET/CT showed more bone lesions in comparison with[18F]FDG PET/CT. Only one patient, [18F]FDG PET/CT showed more bone lesions. Three extramedullary involvements were observed in the following locations: lung, presacral lymph node, and soft tissue mass lateral to the right maxillary sinus. Among these involvements, higher SUVmax values were observed in the lung and presacral lymph node with [68Ga]FAPI compared to [18F]FDG. However, the soft tissue mass showed a higher SUVmax value in [18F]FDG than [68Ga]FAPI. Conclusions: No significant superiority was observed in [68Ga]FAPI PET/CT over [18F]FDG PET/CT in patients with MM. However, [68Ga]FAPI PET/CT can be utilized as a complementary imaging method to [18F]FDG PET/CT in some settings, especially in low-[18F]FDG affinity and inconclusive cases. Considering the favorable aspects of [68Ga]FAPI PET/CT in MM, such as low background activity, absence of non-specific bone marrow, and physiological brain involvement, further studies with a larger sample size should be conducted.

The method for the synthesis of 1,4-dihydropyridine compounds in the presence of Pd–Ni–Ru@GO was developed, which is simple, effective and productive.

No abstract

Highly monodisperse graphene oxide‐supported Ru/Pd nanoparticles (RuPd@GO NPs) have been reproducibly and easily synthesized by microwave assisted method. RuPd@GO NPs was performed for dehalogenation of arylhalides in the presence of ammonia borane in a mild condition as novel, highly efficient and exceptional reusable heterogeneous catalyst. The novel materials were characterized by transmission electron microscopy (TEM), the high resolution electron micrograph (HRTEM), X‐ray diffraction (XRD) and X‐ray photoelectron spectroscopy (XPS). The results showed that the prepared catalysts are highly crystalline, monodisperse and colloidally stable. The current one‐pot catalytic process was described as a new methodology for dehalogenation of arylhalides which can be assessed as a quite simple, eco‐friendly and highly efficient as well as exceptional reusable. All products were provided with one of the highest yield and the shortest time in the presence of novel RuPd@GO NPs due to the the synergistic effect of Ru and Pd. Our synthesis process comes with a facile and eco‐friendly option to RuPd@GO NPs, allowing further scrutiny of current catalysts for numerous other chemical reactions.